Semaglutide (Wegovy and Ozempic) is an FDA-approved GLP-1 agonist that is used to treat obesity, type 2 diabetes, and weight-related health conditions such as metabolic dysfunction-associated steatohepatitis (MASH)
Intake of fruit, vegetables, and fruit juices and risk of diabetes in women
Additionally, the results showed that while semaglutide may result in lower overall weight loss among patients with diabetes than among those who did not have diabetes, there were consistent benefits in symptom reduction and improved quality of life
T., Yamamoto, Y., Gesta, S
InChi Code: InChI=1S/C11H21NO4.ClH/c1-5-6-11(15)16-9(7-10(13)14)8-12(2,3)4,/h9H,5-8H2,1-4H3,1H/t9-,/m1./s1